News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
258,934 Results
Type
Article (13827)
Company Profile (293)
Press Release (244814)
Section
Business (79301)
Career Advice (147)
Deals (13176)
Drug Delivery (31)
Drug Development (50262)
Employer Resources (31)
FDA (5668)
Job Trends (5108)
News (144017)
Policy (10013)
Tag
Academia (901)
Alliances (21438)
Alzheimer's disease (729)
Approvals (5631)
Artificial intelligence (59)
Bankruptcy (97)
Best Places to Work (4457)
Biotechnology (241)
Breast cancer (56)
Cancer (572)
Cardiovascular disease (52)
Career advice (128)
CAR-T (44)
Cell therapy (148)
Clinical research (39581)
Collaboration (202)
Compensation (83)
COVID-19 (998)
C-suite (53)
Cystic fibrosis (61)
Data (612)
Diabetes (64)
Diagnostics (1190)
Earnings (28571)
Events (46493)
Executive appointments (154)
FDA (5910)
Funding (206)
Gene editing (48)
Gene therapy (127)
GLP-1 (290)
Government (1063)
Healthcare (6527)
Infectious disease (1027)
Inflammatory bowel disease (89)
IPO (7168)
Job creations (859)
Job search strategy (124)
Layoffs (181)
Legal (1372)
Lung cancer (101)
Manufacturing (66)
Medical device (2547)
Medtech (2548)
Mergers & acquisitions (6087)
Metabolic disorders (203)
Neuroscience (909)
NextGen Class of 2024 (1996)
Non-profit (841)
Northern California (782)
Obesity (117)
Opinion (90)
Parkinson's disease (55)
Patents (45)
People (24888)
Pharmaceutical (48)
Phase I (13911)
Phase II (18404)
Phase III (11681)
Pipeline (139)
Postmarket research (846)
Preclinical (5869)
Radiopharmaceuticals (203)
Rare diseases (139)
Real estate (1409)
Regulatory (8159)
Research institute (930)
Southern California (721)
Startups (1963)
United States (6568)
Vaccines (153)
Weight loss (74)
Date
Today (164)
Last 7 days (494)
Last 30 days (1804)
Last 365 days (20684)
2024 (17663)
2023 (22412)
2022 (26822)
2021 (27806)
2020 (23357)
2019 (16224)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (146)
Asia (16764)
Australia (2819)
California (1771)
Canada (643)
China (134)
Colorado (65)
Connecticut (70)
Europe (36076)
Florida (191)
Georgia (51)
Illinois (111)
Indiana (51)
Kansas (54)
Maryland (258)
Massachusetts (1474)
Michigan (45)
Minnesota (82)
New Jersey (482)
New York (540)
North Carolina (381)
Northern California (782)
Ohio (72)
Pennsylvania (373)
South America (207)
Southern California (721)
Texas (180)
Washington State (197)
258,934 Results for "monopar therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Monopar Announces CFO Succession
Monopar Therapeutics Inc., a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer patients, announced that after a career spanning more than 35 years, Monopar’s Chief Financial Officer, Kim R. Tsuchimoto, will be retiring.
May 24, 2024
·
4 min read
Press Releases
Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
October 29, 2024
·
4 min read
Business
Monopar and NorthStar Amend & Extend Collaboration
Monopar Therapeutics Inc., a clinical-stage radiopharma company, and NorthStar Medical Radioisotopes, LLC, a global innovator in development and commercial production of medical radioisotopes, announced an amendment and expansion to their existing collaboration.
June 11, 2024
·
6 min read
Press Releases
Monopar Therapeutics Inc. Announces Closing of $19.2 Million Public Offering of Common Stock
October 31, 2024
·
4 min read
Press Releases
Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock
October 29, 2024
·
4 min read
Business
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline
Monopar Therapeutics Inc., a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer patients, announced first quarter 2024 financial results and summarized recent developments.
May 9, 2024
·
7 min read
BioMidwest
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings
Monopar Therapeutics Inc. (Nasdaq: MNPR) today announced that it has filed a provisional patent application pertaining to the recent advancements and optimizations Monopar has achieved with its MNPR-101 radiopharmaceutical program.
April 16, 2024
·
4 min read
BioMidwest
Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24
Monopar Therapeutics Inc. today announced that its abstract titled “Evaluation of Anti-uPAR Antibody as a Radiopharmaceutical for Imaging and Treatment of Solid Tumors” has been accepted as a “Top-Rated Oral Presentation” within the Scientific Program of the European Association of Nuclear Medicine (EANM) 2024 Annual Congress.
June 25, 2024
·
3 min read
Press Releases
Monopar Therapeutics Announces 1-for-5 Reverse Stock Split
August 12, 2024
·
4 min read
Press Releases
Monopar Presents Encouraging Human Clinical Dosimetry Data on its uPAR Program at EANM 2024
October 23, 2024
·
4 min read
1 of 25,894
Next
